Lamotrigina Stada

Lamotrigine, the active ingredient in Lamotrigina Stada, is an antiepileptic (sodium channel blocker) presented as an oral tablet for systemic use. It is indicated for the treatment of various seizure types and for maintenance therapy in bipolar disorder, helping to stabilise neuronal activity in patients of all ages.

GNH USA supplies Lamotrigina Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Lamotrigine is used in the management of seizure disorders and mood stabilization, targeting neuronal excitability.

Partial seizures: reduces frequency and severity of focal seizures in adults and children. Generalized tonic‑clonic seizures: helps achieve seizure control and lowers risk of convulsive episodes. Bipolar disorder (maintenance): stabilises mood and decreases the likelihood of depressive or manic relapse. Adjunctive therapy for refractory focal seizures: used alongside other antiepileptics to improve overall seizure control.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash - Blurred vision - Insomnia

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions such as bullous pemphigoid - Hepatic injury or failure - Suicidal thoughts or behavior

When prescribing lamotrigine, clinicians should observe several precautionary measures to minimise risk. - Dose titration: increase gradually to reduce the risk of rash. - Monitor skin: watch for any rash or hypersensitivity reaction. - Assess hepatic function: adjust dosing in patients with liver impairment. - Avoid abrupt discontinuation: may precipitate seizure recurrence. - Pregnancy: safety data are limited; discuss risks with the patient. - Store at ambient temperature: keep in the original pack, protect from moisture.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid): - Valproate: can markedly increase lamotrigine levels, raising toxicity risk. - Carbamazepine: reduces lamotrigine concentrations, potentially lowering efficacy. - Phenobarbital: induces metabolism and decreases lamotrigine exposure.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may increase lamotrigine clearance, requiring dose adjustment. - Serotonergic agents: monitor for signs of serotonin syndrome. - Other antiepileptics (e.g., phenytoin): may alter lamotrigine levels and require therapeutic monitoring.